tirzepatide data Truveta's real-world study comparing (Mounjaro) and semaglutide (Ozempic) for weight loss published in JAMA Internal Medicine The effects of the drug
Description
It is a triple receptor agonist that targets glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Source: ZipHealth Repost to share insights on evolving pharmacy benefits strategy Follow me for more on pharmacy benefits trends (Bryce Platt, PharmD) | 30 comments on LinkedIn

Lose weight the right way with EliTest Health

The physical, mental and social side effects of Hollywoods secret
Is Semaglutide GLP-1 Effective for Medical Weight Loss?
